BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28461599)

  • 1. Risk Factors for Nonadherence to Antihypertensive Treatment.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Marešová V; White CMJ; Petrák O; Gulsin GS; Patel V; Rosa J; Cole R; Zelinka T; Holaj R; Kinnell A; Smith PR; Thompson JR; Squire I; Widimský J; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Jun; 69(6):1113-1120. PubMed ID: 28461599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Gulsin GS; Beech A; Marešová V; Topham PS; Stanley A; Thurston H; Smith PR; Horne R; Widimský J; Keavney B; Heagerty A; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Nov; 70(5):1042-1048. PubMed ID: 28847892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.
    Kulkarni S; Rao R; Goodman JDH; Connolly K; O'Shaughnessy KM
    Medicine (Baltimore); 2021 Apr; 100(14):e24654. PubMed ID: 33832064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.
    Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015.
    Chang TE; Ritchey MD; Park S; Chang A; Odom EC; Durthaler J; Jackson SL; Loustalot F
    Hypertension; 2019 Dec; 74(6):1324-1332. PubMed ID: 31679429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
    Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.
    Florczak E; Tokarczyk B; Warchoł-Celińska E; Szwench-Pietrasz E; Prejbisz A; Gosk M; Kabat M; Narkiewicz K; Januszewicz A; Kała M
    Pol Arch Med Wewn; 2015; 125(1-2):65-72. PubMed ID: 25578261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department.
    McNaughton CD; Brown NJ; Rothman RL; Liu D; Kabagambe EK; Levy PD; Self WH; Storrow AB; Collins SP; Roumie CL
    Hypertension; 2017 Aug; 70(2):307-314. PubMed ID: 28652467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.
    Durand H; Hayes P; Morrissey EC; Newell J; Casey M; Murphy AW; Molloy GJ
    J Hypertens; 2017 Dec; 35(12):2346-2357. PubMed ID: 28777133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
    Corrêa NB; de Faria AP; Ritter AM; Sabbatini AR; Almeida A; Brunelli V; Calhoun DA; Moreno H; Modolo R
    J Am Soc Hypertens; 2016 Jun; 10(6):510-516.e1. PubMed ID: 27161936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension.
    Gee ME; Campbell NR; Gwadry-Sridhar F; Nolan RP; Kaczorowski J; Bienek A; Robitaille C; Joffres M; Dai S; Walker RL;
    Can J Cardiol; 2012 May; 28(3):383-9. PubMed ID: 22522073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis.
    Abegaz TM; Shehab A; Gebreyohannes EA; Bhagavathula AS; Elnour AA
    Medicine (Baltimore); 2017 Jan; 96(4):e5641. PubMed ID: 28121920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
    Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant hypertension.
    Tobe SW; Lewanczuk R
    Can J Cardiol; 2009 May; 25(5):315-7. PubMed ID: 19417863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.
    Tajeu GS; Kent ST; Kronish IM; Huang L; Krousel-Wood M; Bress AP; Shimbo D; Muntner P
    Hypertension; 2016 Sep; 68(3):565-75. PubMed ID: 27432867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment.
    van Schoonhoven AV; van Asselt ADI; Tomaszewski M; Patel P; Khunti K; Gupta P; Postma MJ
    Hypertension; 2018 Nov; 72(5):1117-1124. PubMed ID: 30354817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives.
    Singh K; Choudhry NK; Krumme AA; McKay C; McElwee NE; Kimura J; Franklin JM
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1299-1308. PubMed ID: 31313427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive medication nonadherence in black men: direct and mediating effects of depressive symptoms, psychosocial stressors, and substance use.
    Cené CW; Dennison CR; Powell Hammond W; Levine D; Bone LR; Hill MN
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):201-9. PubMed ID: 23458593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.